FINANCIAL RELEASES

Date Title View
Toggle Summary Qorvo® Announces Fiscal 2021 Third Quarter Financial Results
GREENSBORO, N.C., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Qorvo ® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, today announced financial results for the Company’s fiscal 2021 third quarter, ended January 2, 2021. On a GAAP basis, revenue for Qorvo’s fiscal 2021
View HTML
Toggle Summary Qorvo® to Present at the Goldman Sachs 2021 Technology and Internet Conference
GREENSBORO, N.C., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, today announced that Company executives are scheduled to present at the Goldman Sachs 2021 Technology and Internet Conference on Thursday, February 11,
View HTML
Toggle Summary Qorvo® to Present at the Raymond James 42nd Annual Institutional Investors Conference
GREENSBORO, N.C., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, today announced that Company executives are scheduled to present at the Raymond James 42nd Annual Institutional Investors Conference on Tuesday, March 2,
View HTML
Toggle Summary Qorvo® to Present at the Morgan Stanley Technology, Media and Telecom Conference
GREENSBORO, N.C., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, today announced that Company executives are scheduled to present at the Morgan Stanley Technology, Media and Telecom Conference on Thursday, March 4, 2021
View HTML
Toggle Summary Qorvo® Biotechnologies Receives FDA Emergency Use Authorization (EUA) for Rapid COVID-19 Antigen Testing
GREENSBORO, N.C., April 15, 2021 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative radio frequency (RF) solutions that connect the world, today announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the Qorvo Omnia™
View HTML
Toggle Summary Qorvo Biotechnologies Awarded $24.4 Million National Institutes of Health Contract to Scale Point-of-Care COVID-19 Antigen Testing
Qorvo Omnia™ diagnostic test platform uses innovative radio frequency technology designed to achieve rapid and specific COVID-19 antigen results GREENSBORO, N.C., April 15, 2021 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative radio frequency (RF) solutions that connect
View HTML
Toggle Summary Qorvo® to Webcast Quarterly Earnings Conference Call on May 5, 2021
GREENSBORO, N.C., April 21, 2021 (GLOBE NEWSWIRE) -- Qorvo ® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, will host a conference call to review fiscal 2021 fourth quarter financial results on Wednesday, May 5, 2021, at 5:00 p.m. (ET).
View HTML
Toggle Summary Qorvo® Announces Fiscal 2021 Fourth Quarter Financial Results
GREENSBORO, N.C., May 05, 2021 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, today announced financial results for the Company’s fiscal 2021 fourth quarter ended April 3, 2021. On a GAAP basis, revenue for Qorvo’s fiscal 2021 fourth
View HTML
Toggle Summary Qorvo® Acquires Leading MEMS-based Sensor Solution Provider NextInput
GREENSBORO, N.C., May 06, 2021 (GLOBE NEWSWIRE) -- Qorvo ® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, announced today that it has acquired Mountain View, California-based NextInput, a pioneer in the emerging field of force-sensing solutions for
View HTML
Toggle Summary Qorvo® Appoints Judy Bruner to its Board of Directors
GREENSBORO, N.C., May 12, 2021 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, today announced the election of Judy Bruner to its Board of Directors, effective immediately. Ms. Bruner will also join the Board’s Audit and Governance
View HTML